Financials

  • Market Capitalization 534.24 M
  • Employee 246
  • Founded 2013
  • CEO N/A
  • Website www.arvinas.com
  • Headquarter Delaware, United States
  • FIGI BBG00LW7YK82
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.33
ratio cours/chiffre d'affaires
8.43

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2839
IMMX
Immix Biopharma, Inc. - Common Stock
10.53 USD-1.40%-4.27%+23.88%+273.40%572.95 M USD
2850
DNA
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
9.02 USD-0.33%-1.96%+10.95%+1.58%562.17 M USD
2911
NVCT
Nuvectis Pharma, Inc. - Common Stock
19.59 USD+7.11%+4.48%+74.29%+139.19%519.64 M USD
2914
ZURA
Zura Bio Limited - Class A Ordinary shares
5.39 USD+6.52%-1.82%+46.87%+308.33%512.04 M USD

Nouvelles